BeStock  
Stocks › Biotechnology › SGMT

Sagimet Biosciences SGMT

US equityMarket cap rank #3594Biotechnology
$8.88 +$0.12 (+1.37%)
Pre-market · Oct 8, 8:20 am ET · After hours $8.88 0.00%
Open$8.65
Prev close$8.76
Day range$8.60 – $8.97
Volume631.6K
Market cap$629.67M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$15.82M-32.6% YoY
Net profit-$13.95M-34.3% YoY
Diluted EPS-$0.26+18.8% YoY
Free cash flow-$11.10M-22.0% YoY
Operating cash flow-$11.10M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-14.6MSep '24$-16.2MDec '24$-18.2MMar '25$-10.4MJun '25$-12.9MSep '25$-9.6MDec '25$-10.7MMar '26$-14.0MJun '26

Diluted EPS by quarter

-0.45Sep '24-0.50Dec '24-0.56Mar '25-0.32Jun '25-0.40Sep '25-0.29Dec '25-0.33Mar '26-0.26Jun '26

Free cash flow by quarter

$-19.6MSep '24$-11.0MDec '24$-14.5MMar '25$-9.1MJun '25$-10.2MSep '25$-11.8MDec '25$-8.6MMar '26$-11.1MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$2.0MFY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-24.4%
Return on assets-23.5%
Return on invested capital-27.0%
Current ratio45.02
Liabilities / assets2.8%
Cash & investments$240.13M
Total debt$1.86M
Net cash (debt)$238.27M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $15.82M $11.71M $56.89M $10.77M $14.33M
Selling and Admin Expenses $4.28M $4.72M $17.84M $4.03M $4.60M
-General & Admin Expense $4.28M $4.72M $17.84M $4.03M $4.60M
Research & Development $11.54M $7.00M $39.05M $6.73M $9.73M
Operating Profit -$15.82M -$11.71M -$56.89M -$10.77M -$14.33M
Net Non-Operating Interest Income (Expense) $1.87M $1.06M $5.85M $1.20M $1.43M
Non-Operating Interest Income $1.87M $1.06M $5.85M $1.20M $1.43M
Pretax Profit -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Net Profit -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Profit from Continuing Operations -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Net Income to Parent Company -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Net Income to Common Stockholders -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Basic EPS -$0.26 -$0.33 -$1.58 -$0.29 -$0.40
Diluted EPS -$0.26 -$0.33 -$1.58 -$0.29 -$0.40

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $263.43M $107.76M $116.48M $116.48M $128.40M
Total Current Assets $243.99M $107.72M $116.40M $116.40M $119.48M
Cash and Cash Equivalents & Short-Term Investments $240.13M $104.54M $113.12M $113.12M $116.69M
-Cash and Cash Equivalents $165.90M $36.63M $35.02M $35.02M $32.50M
-Short Term Investments $74.23M $67.91M $78.10M $78.10M $84.20M
Prepaid Assets $3.20M $2.53M $2.80M $2.80M $2.29M
Current Deferred Assets $434,000.00 $402,000.00 $282,000.00 $282,000.00 $247,000.00
Other Current Assets $226,000.00 $248,000.00 $199,000.00 $199,000.00 $253,000.00
Total Non-Current Assets $19.44M $39,000.00 $78,000.00 $78,000.00 $8.92M
Net PPE $1.95M $39,000.00 $78,000.00 $78,000.00 $115,000.00
-Gross PPE $1.95M $39,000.00 $78,000.00 $78,000.00 $115,000.00
Investments and Advances $17.44M – $0.00 $0.00 $8.81M
-Available for Sale Securities $17.44M – – – $8.81M
Other Non-Current Assets $55,000.00 – – – –
Total Liabilities $7.28M $5.30M $5.10M $5.10M $9.15M
Total Current Liabilities $5.42M $5.30M $5.10M $5.10M $9.15M
Payables $1.13M $2.30M $1.31M $1.31M $4.24M
-Accounts Payable $1.13M $2.30M $1.31M $1.31M $4.24M
Current Accrued Expenses $4.18M $2.94M $3.69M $3.69M $4.78M
Short-Term Debt and Capital Lease Obligation $84,000.00 $39,000.00 $78,000.00 $78,000.00 $115,000.00
-Current Capital Lease Obligation $84,000.00 $39,000.00 $78,000.00 $78,000.00 $115,000.00
Other Current Liabilities $26,000.00 $15,000.00 $27,000.00 $27,000.00 $8,000.00
Total Non-Current Liabilities $1.86M $0.00 $0.00 $0.00 $0.00
Long Term Debt and Capital Lease Obligation $1.86M – – – –
-Long Term Capital Lease Obligation $1.86M – – – –
Total Equity $256.16M $102.46M $111.38M $111.38M $119.26M
Stockholders' Equity $256.16M $102.46M $111.38M $111.38M $119.26M
Capital Stock $6,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $6,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $627.18M $459.45M $457.61M $457.61M $455.92M
Retained Earnings -$370.95M -$357.00M -$346.35M -$346.35M -$336.78M
Gains/Losses Not Affecting Retained Earnings -$77,000.00 $8,000.00 $120,000.00 $120,000.00 $117,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$11.10M -$8.61M -$45.65M -$11.83M -$10.18M
Net cash flow from continuing operations -$11.10M -$8.61M -$45.65M -$11.83M -$10.18M
Net Income from Continuing Operations -$13.95M -$10.65M -$51.04M -$9.57M -$12.91M
Other Non-Cash Items $39,000.00 $39,000.00 $151,000.00 $37,000.00 $37,000.00
Change in Working Capital -$859,000.00 $301,000.00 -$1.05M -$4.29M $701,000.00
-Change in Prepaid Assets -$529,000.00 -$297,000.00 -$1.83M -$283,000.00 -$825,000.00
-Change in Payables and Accrued Expense -$236,000.00 $637,000.00 $929,000.00 -$3.97M $1.56M
-Change in Other Current Liabilities -$39,000.00 -$39,000.00 -$152,000.00 -$37,000.00 -$37,000.00
Net cash flow from investing -$24.02M $10.22M $4.56M $14.36M $75,000.00
Net Cash Flow from Continuing Investing Activities -$24.02M $10.22M $4.56M $14.36M $75,000.00
Net Investment Purchase and Sale -$24.02M $10.22M $4.56M $14.36M $75,000.00
Ending Cash Balance $165.90M $36.63M $35.02M $35.02M $32.50M
Net Change in Cash $129.27M $1.61M -$40.82M $2.53M -$9.83M
Beginning Cash Balance $36.63M $35.02M $75.84M $32.50M $42.33M
Free Cash Flow -$11.10M -$8.61M -$45.65M -$11.83M -$10.18M
Financing Cash Flow – – $275,000.00 $0.00 $274,000.00
Net Cash Flow from Continuing Financing Activities – – $275,000.00 $0.00 $274,000.00
Net Common Stock Issuance – – $0.00 $0.00 $0.00
Proceeds from Stock Option Exercised – – $275,000.00 $0.00 $274,000.00

Discussion

No comments yet — be the first to weigh in on SGMT.

Leave a comment

Scroll to Top